 |
|
|
| |
EFFICACY AND SAFETY OF GRAZOPREVIR AND ELBASVIR IN HEPATITIS C GENOTYPE 1-INFECTED PATIENTS WITH CHILD-PUGH CLASS B CIRRHOSIS (C-SALT PART A)
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Ira M. Jacobson* 1, Fred Poordad2, Roberto Firpi-Morell3, Gregory T. Everson4, Elizabeth C. Verna5, Sanhita Bhanja6, Boan Zhang6, Luzelena Caro6, Janice Wahl6, Michael Robertson6, Eliav Barr6, Edgar D. Charles6
1Weill Cornell Medical College, New York, 2The Texas Liver Institute, University of Texas Health Science Center, San Antonio, 3University of Florida, Gainesville, 4University of Colorado, Aurora, 5Columbia University, New York, 6Merck & Co., Inc., Whitehouse Station, United States
|
| |
|
|
|
|
|
